Cargando…
Circulating and intrahepatic antiviral B cells are defective in hepatitis B
B cells are increasingly recognized as playing an important role in the ongoing control of hepatitis B virus (HBV). The development of antibodies against the viral surface antigen (HBV surface antigen [HBsAgs]) constitutes the hallmark of resolution of acute infection and is a therapeutic goal for f...
Autores principales: | Burton, Alice R., Pallett, Laura J., McCoy, Laura E., Suveizdyte, Kornelija, Amin, Oliver E., Swadling, Leo, Alberts, Elena, Davidson, Brian R., Kennedy, Patrick T.F., Gill, Upkar S., Mauri, Claudia, Blair, Paul A., Pelletier, Nadege, Maini, Mala K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159997/ https://www.ncbi.nlm.nih.gov/pubmed/30091725 http://dx.doi.org/10.1172/JCI121960 |
Ejemplares similares
-
Fine needle aspirates comprehensively sample intrahepatic immunity
por: Gill, Upkar S, et al.
Publicado: (2019) -
Liver sampling: a vital window into HBV pathogenesis on the path to functional cure
por: Gill, Upkar S, et al.
Publicado: (2018) -
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion
por: Peppa, Dimitra, et al.
Publicado: (2013) -
Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID‐19
por: Burton, Alice R., et al.
Publicado: (2021) -
Isolation of human intrahepatic leukocytes for phenotypic and functional characterization by flow cytometry
por: Kucykowicz, Stephanie, et al.
Publicado: (2022)